FHTX   $7.89  2.20% Market Closed After Close 7.84 -0.63%

Foghorn Therapeutics Inc.
Total Cash 267.40M
totalCashPerShare 4.81
EBITDA -98.53M
Total Debt 39.07M
quickRatio 4.706
currentRatio 4.773
Total Revenue 25.52M
debtToEquity
Revenue/Share 0.513
ROA -0.20452
ROE
grossProfits
freeCashflow -42.25M
operatingCashflow -103.43M
earningsGrowth
revenueGrowth -0.553
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -3.05482
profitMargins 0.0
enterpriseValue 268.68M
forwardPE -5.9612904
floatShares 26.01M
sharesOutstanding 55.33M
sharesShort 1.33M
sharesShortPriorMonth 1.10M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.19%
heldPercentInstitutions 0.72%
Short Ratio help_outline 6.83%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -0.509
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -91.22M
trailingEps -1.85%
forwardEps -1.55%
enterpriseToEbitda -2.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.43 4Q 2024
institutionsCount 108
lastUpdated Nov. 7, 2024, 3:27 a.m.